Tag: NJ BIO, INC

Suven Pharmaceuticals to Acquire Controlling Stake in NJ Bio, Inc.

Dec 7, 2024

—

by

Amir El-Sayed

in general invests

Hyderabad’s Suven Pharmaceuticals plans to acquire a 56% stake in Princeton-based NJ Bio, Inc. This acquisition is valued at USD 100 million, combining both primary and secondary investments. The move aims to expand Suven’s foothold in the biotechnology sector. Suven Pharmaceuticals, based in Hyderabad, has announced its plan to acquire a controlling interest in NJ…